Clindamycin

Clindamycin and Benzoyl Peroxide Gel is indicated for the topical treatment of mild to moderate acne vulgaris, particularly inflammatory lesions, in adults and adolescents aged 12 years and above. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Clindamycin Injection USP (clindamycin injection) is indicated for the treatment of serious infections due to susceptible anaerobic bacteria, such as Bacteroides species, Peptostreptococcus, anaerobic streptococci, Clostridium species and microaerophilic streptococci.

Clindamycin Injection USP is also indicated for the treatment of serious infections due to susceptible strains of gram positive aerobic bacteria (staphylococci, including penicillinase - producing staphylococci, streptococci and pneumococci) as well as in the treatment of Chlamydia trachomatis, when the patient is intolerant of, or the organism is resistant to other appropriate antibiotics.

Because of the risk of Clostridium difficile-associated disease (CDAD) as described in 7 WARNINGS AND PRECAUTIONS section, before selecting clindamycin the healthcare professional should consider the nature of the infection and the suitability of alternative therapy.

Clindamycin Injection USP is indicated for the treatment of the following serious infections when caused by susceptible strains of the designated organisms in the conditions listed below:  Lower respiratory infections including pneumonia, empyema, and lung abscess when caused by anaerobes, Streptococcus pneumoniae, other streptococci (except Enterococcus faecalis) and Staphylococcus aureus.

INDICATIONS AND USAGE

Clindamycin phosphate topical lotion is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).